Page 2 - Largest Hong Kong (HSI) Pharmaceuticals & Biotech Stocks by Market Cap

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
2162 Keymed Biosciences	HK$33.65	13.1%	-46.2%	HK$9.3b	HK$58.98	PS24.3x	E-8.9%	n/a
719 Shandong Xinhua Pharmaceutical	HK$5.34	0.8%	-19.5%	HK$9.2b	n/a	PE6.8x	n/a	5.1%
9969 InnoCare Pharma	HK$4.33	-3.1%	-53.2%	HK$8.6b	HK$9.73	PS9.5x	E23.7%	n/a
2696 Shanghai Henlius Biotech	HK$15.70	7.8%	8.4%	HK$8.5b	HK$17.78	PE14.5x	E15.9%	n/a
6185 CanSino Biologics	HK$18.06	0.1%	-53.1%	HK$8.3b	HK$26.33	PS11.6x	E124.2%	0%
3613 Beijing Tong Ren Tang Chinese Medicine	HK$9.26	2.5%	-42.1%	HK$7.8b	HK$13.93	PE14.3x	E15.2%	3.6%
1952 Everest Medicines	HK$23.50	1.5%	63.4%	HK$7.6b	HK$28.05	PS55.2x	E80.2%	n/a
2157 Lepu Biopharma	HK$4.50	7.1%	-14.6%	HK$7.5b	HK$3.70	PS30.7x	S11.0%	n/a
2877 China Shineway Pharmaceutical Group	HK$9.33	0.3%	9.8%	HK$7.0b	HK$14.09	PE6.7x	E14.5%	6.2%
1349 Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd	HK$2.12	1.4%	-33.3%	HK$6.3b	n/a	PE18.7x	n/a	3.6%
1666 Tong Ren Tang Technologies	HK$4.82	-2.6%	-37.4%	HK$6.2b	HK$6.55	PE9.7x	E4.5%	4.0%
1541 ImmuneOnco Biopharmaceuticals (Shanghai)	HK$14.64	1.9%	n/a	HK$5.4b	HK$21.50	PS13124.9x	S58.1%	n/a
2509 Qyuns Therapeutics	HK$25.00	7.8%	n/a	HK$5.1b	n/a	PS374.6x	n/a	n/a
6955 Shandong Boan Biotechnology	HK$10.00	-1.6%	-39.6%	HK$5.1b	HK$11.30	PS7.6x	S27.8%	n/a
2480 Beijing Luzhu Biotechnology	HK$24.50	23.9%	n/a	HK$5.0b	HK$35.13	PB4.5x	E40.6%	n/a
460 Sihuan Pharmaceutical Holdings Group	HK$0.53	3.9%	-33.8%	HK$4.9b	n/a	PS2.4x	E117.7%	0%
6855 Ascentage Pharma Group International	HK$17.22	2.1%	-25.5%	HK$4.8b	HK$29.48	PS20.4x	E17.7%	n/a
1681 Consun Pharmaceutical Group	HK$5.63	1.4%	16.1%	HK$4.5b	HK$7.87	PE5.3x	E14.4%	10.6%
2179 Jiangsu Recbio Technology	HK$9.17	1.1%	-30.5%	HK$4.4b	HK$15.00	PS133.8x	E-3.4%	n/a
9966 Alphamab Oncology	HK$4.41	3.3%	-71.7%	HK$4.3b	HK$4.56	PS18x	E1.6%	n/a
1477 Ocumension Therapeutics	HK$6.03	2.2%	-33.3%	HK$4.2b	HK$8.41	PS15.7x	E93.7%	n/a
775 CK Life Sciences Int'l. (Holdings)	HK$0.34	1.5%	-56.3%	HK$3.3b	n/a	PE192.2x	n/a	0%
2315 Biocytogen Pharmaceuticals (Beijing)	HK$7.74	14.7%	-67.9%	HK$3.1b	HK$15.39	PS4x	E100.1%	n/a
2171 CARsgen Therapeutics Holdings	HK$5.05	12.5%	-59.3%	HK$2.9b	HK$8.61	PB1.5x	E15.8%	n/a